-
Innovation Ranking
NewInnovation Ranking – GB Group PLC
GB Group PLC (GB Group) is a provider of identity data intelligence services. The company offers fraud, risk and compliance solutions including business decisions automation, documents validation, application fraud detection, customer behaviour monitoring, and fraud sharing and access services. It also offers location and customer intelligence services including global address validation, global telephone number validation, bank account validation and email validation services. GB Group offers ID (identity document) verification, ID registration, ID engagement, ID trace and investigate solutions, ID employ...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GB-2064 in Myelofibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GB-2064 in Myelofibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GB-2064 in Myelofibrosis Drug Details: GB-2064 (PAT-1251) Is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GB-2064 in Post-Polycythemia Vera Myelofibrosis (PPV-MF)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GB-2064 in Post-Polycythemia Vera Myelofibrosis (PPV-MF) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GB-2064 in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Drug Details: GB-2064 (PAT-1251)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GB-2064 in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GB-2064 in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GB-2064 in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) Drug Details:...
-
Product Insights
GBS Suria Solar PV Park
GBS Suria Solar PV Park is a solar PV project located in Malaysia. The project is owned and being developed by GBS Suria Sdn Bhd. The project is at the permitting stage. Empower your strategies with our GBS Suria Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GB-1211 in Decompensated Cirrhosis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GB-1211 in Decompensated Cirrhosis Drug Details: GB-1211 is under development for the treatment of liver cirrhosis,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GB-1211 in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GB-1211 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: GB-1211 is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – HB-101 in Cytomegalovirus (HHV-5) Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HB-101 in Cytomegalovirus (HHV-5) Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HB-101 in Cytomegalovirus (HHV-5) Infections Drug Details: HB-101 (Vaxwave) is under...
-
Company Insights
Innovation and Patenting activity of GB Group PLC Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of GB Group PLC Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GB-1211 in Liver Cirrhosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GB-1211 in Liver Cirrhosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GB-1211 in Liver Cirrhosis Drug Details: GB-1211 is under development for the...